Veeva Commercial Cloud gaining momentum as 14 life sciences companies
adopt Veeva CRM Events Management in just over a year
PLEASANTON, Calif.--(BUSINESS WIRE)--
As the life sciences industry shifts to multichannel customer
engagement, Veeva
Systems (NYSE:VEEV) announced that six of the 20 largest
pharmaceutical companies and a total of 14 customers in just over a year
have adopted Veeva
CRM Events Management, a single solution for end-to-end management
of live and virtual events. Veeva CRM Events Management is part of the
suite of Veeva
Commercial Cloud applications helping life sciences organizations
market and sell more effectively.
Companies are rapidly adopting integrated, cloud-based solutions for a
holistic approach to customer engagement. Over the next five years,
Gartner expects migration to multichannel sales and marketing to
strengthen and grow within the life sciences industry.1 Veeva
delivers a suite of cloud applications to give commercial teams a
comprehensive view of customer engagement – including face-to-face,
online, and events – for greater insight about healthcare professionals.
Veeva CRM Events Management provides one source for enterprise-wide
event planning and execution to streamline approval workflows, reduce
bottlenecks, and keep events on schedule. Companies have total
visibility of speakers, attendees, activities, and expenditures for all
global events to reduce event management complexity. As a result, life
sciences companies can improve compliance and increase the efficiency of
meeting and event execution. In just over a year, Veeva CRM Events
Management has quickly established itself as a leading choice for life
sciences companies to better orchestrate their customer engagement
strategies.
For example, Sanofi Pasteur MSD replaced its local event planning system
in Germany with Veeva CRM Events Management in its ongoing drive toward
multichannel engagement. “Veeva CRM Events Management aggregates all
spend and speaker data in one system that’s integrated with our CRM so
that we can measure event success as part of our multichannel strategy,”
said Alexandre Gultzgoff, Sanofi Pasteur MSD’s deputy director of IT.
“We also now have a consolidated view of all customer interactions to
ensure compliance with regional EFPIA and local transparency spend rules
in Europe.”
“We began developing Veeva CRM Events Management based on customer
demand for a single, end-to-end solution to manage events,” said Paul
Shawah, vice president of commercial cloud strategy at Veeva. “It has
been a powerful addition to Veeva Commercial Cloud, helping the life
sciences industry continuously coordinate and build stronger
relationships with their customers.”
Additional Information
For more on Veeva CRM Events Management, visit: veeva.com/crmevents
Stay
updated on the latest Veeva news on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 450 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended July 31, 2016. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
1 Stephen Davies (Gartner: March 18, 2016), Market Guide for
CRM in Pharma and Biotech
View source version on businesswire.com: http://www.businesswire.com/news/home/20160913005676/en/
Source: Veeva Systems Inc.